Journal of Clinical Endocrinology & Metabolism
Sermorelin: a review of its use in the diagnosis and treatment of growth hormone deficiency
1999 · PMID 10543625
Walker RF.
View source
Secretagogue Compound
Sermorelin
GHRH(1-29)amide — the biologically active N-terminal fragment of growth hormone-releasing hormone, used in GHRH receptor research.
Quantity
Units
1
Price
$32.99Out of stock
Est. delivery Thu, Jul 30–Wed, Aug 5 · COA included · Same-day ship before 2PM PT
Apple Pay · Google Pay · Visa · Amex · Discover
Compound information
Molecular profile
Technical specifications for laboratory reference
Molecular profile
What is Sermorelin?
GHRH(1-29)amide — the biologically active N-terminal fragment of growth hormone-releasing hormone, used in GHRH receptor research.
- Type
- GHRH fragment
- CAS Number
- 86168-78-7
- Molecular Weight
- 3,358.8 g/mol
- Amino Acids
- 29
Storage requirements
Stability information
Cold chainProtect from light
Lyophilized (powder)
−20°C · up to 24 months
Reconstituted
2–8°C · up to 21 days
Literature
Sources & references
Peer-reviewed research for laboratory background
Citations are provided for research background only. Peptide Club materials are sold for laboratory research use — not for human or veterinary consumption. References do not constitute product claims.
